Search
Ravulizumab
go.drugbank.com/drugs/DB11580ApprovedInvestigational[A244465] It was later approved by the European Commission on July 2, 2019, for the same indications.[L39710] Ravulizumab is also used to treat myasthenia gravis. … [A244465] Ravulizumab was first approved by the FDA on December 21, 2018, for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome in children and adults.
Products: Ultomiris 100mg/mL Concentrate For Solution For InfusionColistimethate
go.drugbank.com/drugs/DB01111ApprovedInvestigationalVet approvedColistimethate is an antibiotic that has been shown to have bactericidal activity against aerobic gram-negative microorganisms. Colistimethate is particularly indicated when the infection is caused by sensitive strains of Pseudomonas aer...
Products: Colomycin Injection 1 million International Units, POWDER FOR SOLUTION FOR INJECTION, INFUSION, OR INHALATION, Colistimethate for Injection, USPBotulinum toxin type A
go.drugbank.com/drugs/DB00083ApprovedInvestigational[A231819,L32569] A popular use for Botox is the treatment of facial wrinkles and lines, however, there are many uses for the botulinum toxin A in the treatment of dystonia, incontinence, migraine, blepharospasm … In 2002, botulinum toxin A, also known as onabotulinumtoxinA or Botox, was the first type A botulism toxin to be introduced into the market for cosmetic use.
Products: XEOMIN powder for solution for injection 100 LD50 units, Neuronox ® Powder for Solution for Injection 100 unitsSodium phosphate, dibasic, unspecified form
go.drugbank.com/drugs/DB14504ApprovedMixtures: Medline Saline Laxative For Children, FLEET READY-TO-USE ENEMA FOR CHILDRENSynonyms: Sodium phosphate, dibasic, unspecified formTrastuzumab
go.drugbank.com/drugs/DB00072ApprovedInvestigationalWhile Ogivri is the first biosimilar approved in the U.S. for the treatment of breast cancer or stomach cancer, it is the second biosimilar approved in the U.S. for the treatment of cancer. … In December 2017, FDA approved OGIVRI (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction
Products: Herzuma (trastuzumab) 150 mg Powder for Concentrate for Solution for Infusion, HERZUMA® 440MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSIONSitotroga cerealella
go.drugbank.com/drugs/DB10903ApprovedSitotroga cerealella allergenic extract is used in allergenic testing.
Synonyms: grain moth extractDL-alpha tocopheryl acetate
go.drugbank.com/drugs/DB14477ApprovedSynonyms: all-rac-alfa-tocopheryl acetate, all-rac-alpha-tocopheryl acetateMixtures: Fizz Multivitamins for Kids W C Loz, Poly Vi Flor Chewable TabSynthetic camphor
go.drugbank.com/drugs/DB14156ApprovedMixtures: StingEze with Aloe for kids, MAKESENSE with Aloe Vera and Vitamin EProducts: AllG Pain Relief Fast Acting Pain, ALLG Essentials Warm-up AcceleratorKoeleria macrantha pollen
go.drugbank.com/drugs/DB10949ApprovedKoeleria macrantha pollen is the pollen of the Koeleria macrantha plant. Koeleria macrantha pollen is mainly used in allergenic testing.
Categories: Grass Pollen Allergen ExtractsSynonyms: Koelers grass pollen extract, Standardized june grass pollenInfliximab
go.drugbank.com/drugs/DB00065ApprovedInvestigationalThey are approved for all eligible indications of the reference product. Inflectra, a first biosimilar drug product, was approved in 2016. … It is indicated for the treatment of various inflammatory disorders such as adult or pediatric Chron's disease, adult or pediatric ulcerative colitis, rheumatoid arthritis in combination with methotrexate
Categories: Biologics for Rheumatoid Arthritis TreatmentProducts: POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL, REMICADE POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 mg/vial